Oral Tranexamic Acid Enhances the Efficacy of Low-Fluence 1064-Nm Quality-Switched Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment for Melasma in Koreans: A Randomized, Prospective Trial
Authors:
- Jung U ShinJSJung U Shin
- Jihun ParkJPJihun Park
- Sang Ho OhSOSang Ho Oh
- Ju Hee LeeJLJu Hee Lee
- 1 March 2013
- journal article
- research article
- Published by Wolters Kluwer Health in Dermatologic Surgery
- Vol. 39 (3) , 435-442
Abstract
Tranexamic acid (TA) has recently gained in popularity in the treatment of pigmentary disorders. To evaluate the clinical efficacy and safety of oral TA combined with low-fluence 1064-nm quality-switched neodymium-doped yttrium aluminum garnet (QSNY) laser for the treatment of melasma. Forty-eight patients with melasma were enrolled in the study and subsequently divided into two groups: a combination group and a laser treatment group. All patients were treated with two sessions of low-fluence QSNY laser, and patients in the combination group took 8 weeks of oral TA. Two blinded dermatologists evaluated patients using the Modified Melasma Area and Severity Index (mMASI) and a clinical improvement scale. Mean mMASI score 4 weeks after the second treatment decreased significantly in both groups from base line. Based on overall clinical improvement, a greater number of patients scored as grade 3 and more in the combination group; no patients were scored as grade 4 in the laser-alone group. Oral TA may prove a safe and efficient treatment option for melasma in combination with low-fluence QSNY laser therapy.Keywords
This publication has 19 references indexed in Scilit:
- Efficacy and Safety of Q-Switched 1,064-nm Neodymium-Doped Yttrium Aluminum Garnet Laser Treatment of MelasmaDermatologic Surgery, 2011
- Reliability assessment and validation of the Melasma Area and Severity Index (MASI) and a new modified MASI scoring methodJournal of the American Academy of Dermatology, 2011
- Efficacy of the 1064-nm Q-switched Nd:YAG laser in melasmaJournal of Dermatological Treatment, 2010
- Therapeutical Approaches in MelasmaDermatologic Clinics, 2007
- The treatment of melasma: A review of clinical trialsJournal of the American Academy of Dermatology, 2006
- Localized Intradermal Microinjection of Tranexamic Acid for Treatment of Melasma in Asian PatientsDermatologic Surgery, 2006
- Treatment of melasmaJournal of the American Academy of Dermatology, 2006
- Development of novel topical tranexamic acid liposome formulationsInternational Journal of Pharmaceutics, 2002
- MelasmaArchives of Dermatology, 1995
- Influence of Inflammatory Mediators and Cytokines on Human Melanocyte FunctionJournal of Investigative Dermatology, 1993